At close: December 16 at 4:00:00 PM EST
After hours: December 16 at 6:51:47 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 363k | -- |
| Low Estimate | -- | -- | 363k | -- |
| High Estimate | -- | -- | 363k | -- |
| Year Ago Sales | -- | -- | -- | 363k |
| Sales Growth (year/est) | -- | -- | -- | -100.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|
| EPS Est. | -- | -1.04 | -0.96 |
| EPS Actual | -1.28 | -0.96 | -1.29 |
| Difference | -- | 0.08 | -0.33 |
| Surprise % | -- | 7.69% | -34.38% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LIPO | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Initiated | Maxim Group: Buy | 4/9/2024 |
Related Tickers
CYCC Cyclacel Pharmaceuticals, Inc.
0.3433
-4.93%
ALLR Allarity Therapeutics, Inc.
0.9550
-6.37%
PLRZ Polyrizon Ltd.
1.0000
+1.82%
DRMA Dermata Therapeutics, Inc.
1.0700
-1.83%
CHRO Channel Therapeutics Corporation
0.5911
+1.03%
REVB Revelation Biosciences, Inc.
0.3480
-3.33%
RLYB Rallybio Corporation
1.0300
-4.63%
ACOG Alpha Cognition Inc. Common Stock
4.7900
-11.62%
SLXN Silexion Therapeutics Corp
3.2500
-7.67%
IMNN Imunon, Inc.
0.8400
+0.60%